Implant Practice US provides continuing education and other valuable resources to help you build upon your expertise in implantology. Our continuing education is updated regularly and accessible any time, from anywhere.
Become a subscriber today!

BioHorizons® Biologics

141024 Biohorizons FeatureOptimal choices to support predictable implant therapy

It’s no secret that predictable implant treatment planning often begins with proper soft and hard tissue regeneration to facilitate sufficient initial implant stability. Historically, aside from implants and related prosthetic components, implant companies rarely provided adjunct products to support other major steps in treatment.

In 1998, BioHorizons began distribution of Grafton® Demineralized Bone Matrix (DBM) and became one of the first dental implant companies to feature a regenerative product line. Since the launch of Grafton DBM, BioHorizons has added a variety of key biologics products to support soft and hard tissue regeneration. AlloDerm® Regenerative Tissue Matrix (RTM) is the market leader in soft tissue alternatives with 118 peer-reviewed published studies in dental since 2000. MinerOss® cortical and cancellous chips was the first blended allograft particulate offered in implant dentistry in 2004. MinerOss is now distributed in over 35 countries. 141024 Biohorizons 01

Features of the MinerOss family of bone grafts include:

MinerOss cortical and cancellous chips offers a unique blend to form an osteoconductive scaffold providing volume enhancement and effective site development.

MinerOss Cancellous allograft particulate launched in 2012, and MinerOss Cortical particulate launched in 2013.

MinerOss X family of xenografts, an anorganic bovine bone mineral matrix that is physically and chemically comparable to the mineral structure of human bone, launched in 2014.

The ability to offer complete solutions from first surgery to final restoration provides clinicians with a streamlined approach to

implant practice management. BioHorizons is recognized as a global leader for scientifically proven tissue regeneration solutions.

About BioHorizons

BioHorizons, Inc., a majority-owned subsidiary of Henry Schein, Inc. (NASDAQ: HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit www.biohorizons.com.141024 Biohorizons 02

Stay Relevant With Implant Practice US

Join our email list for CE courses and webinars, articles and mores

SUBSCRIBE TODAY

Implant Practice US is a leading dental journal and publication for dental implantology continuing education, oral implantology case studies, and more. Subscribe to Implant Practice US today!

ONLINE DENTAL CE

Earn dental continuing education credits as an Implant Practice US subscriber. Log in for online dental CE credits now!

Other Dental Publications

AGD PACE MedMark White

SUBSCRIBE TODAY

Implant Practice US is a leading dental journal and publication for dental implantology continuing education, oral implantology case studies, and more. Subscribe to Implant Practice US today!

ONLINE DENTAL CE

Earn dental continuing education credits as an Implant Practice US subscriber. Log in for online dental CE credits now!

Other Dental Publications

Copyright © 2024 Orthodontic Practice US - Dental Journal and Online Dental CE | MedMark LLC
15720 North Greenway Hayden Loop, Suite #9 Scottsdale, AZ 85260 | All rights Reserved | Privacy Policy | Terms & Conditions

Shopping Cart
Scroll to Top